CURTI, Erica
 Distribuzione geografica
Continente #
NA - Nord America 312
EU - Europa 191
AS - Asia 130
Totale 633
Nazione #
US - Stati Uniti d'America 310
IE - Irlanda 69
SG - Singapore 62
CN - Cina 53
SE - Svezia 39
IT - Italia 21
FI - Finlandia 17
DE - Germania 15
GB - Regno Unito 13
IN - India 7
TR - Turchia 7
BE - Belgio 5
UA - Ucraina 5
FR - Francia 4
CA - Canada 2
CH - Svizzera 2
ID - Indonesia 1
NL - Olanda 1
Totale 633
Città #
Dublin 69
Santa Clara 55
Singapore 50
Chandler 41
Ann Arbor 25
Ashburn 19
Helsinki 17
Boardman 13
Princeton 13
Dearborn 12
Shanghai 12
Wilmington 11
Beijing 9
Nanjing 8
Des Moines 7
Woodbridge 7
Brussels 5
Redwood City 5
Como 4
Kocaeli 4
Borås 3
Changsha 2
Fairfield 2
Falkenstein 2
Fremont 2
Hebei 2
Houston 2
Izmir 2
Jinan 2
Lanzhou 2
Milan 2
Munich 2
Nanchang 2
New York 2
Padova 2
Parma 2
Sassuolo 2
Seattle 2
Augusta 1
Bremen 1
Bursa 1
Frankfurt am Main 1
Grafing 1
Haikou 1
Jakarta 1
Jiaxing 1
London 1
Mountain View 1
Ningbo 1
Norwalk 1
Rockville 1
San Jose 1
San Mateo 1
Secaucus 1
Shenyang 1
Shenzhen 1
Taizhou 1
Tangshan 1
Tianjin 1
Toronto 1
Zhengzhou 1
Totale 446
Nome #
First-line disease-modifying drugs in relapsing–remitting multiple sclerosis: an Italian real-life multicenter study on persistence 74
Correlation between cortical lesions and cognitive impairment in multiple sclerosis 69
Neuromyelitis Optica Spectrum Disorder Attack Triggered by Herpes Zoster Infection 60
Five- and seven-year prognostic value of new effectiveness measures (NEDA, MEDA and six-month delayed NEDA) in relapsing-remitting multiple sclerosis 54
Location of first attack predicts the site of subsequent relapses in multiple sclerosis 53
Secondary cluster headache due to a contralateral demyelinating periaqueductal gray matter lesion 52
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 51
The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary? 47
The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study 45
Spinal cord lesions are frequently asymptomatic in relapsing–remitting multiple sclerosis: a retrospective MRI survey 45
Successful intravenous immunoglobulin treatment in relapsing MOG-antibody-associated disease 42
Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience 35
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 32
Totale 659
Categoria #
all - tutte 3.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202079 0 0 0 0 0 0 14 2 4 17 23 19
2020/202143 1 4 4 3 6 3 1 3 8 6 4 0
2021/202263 0 5 0 3 5 1 8 5 0 3 4 29
2022/2023201 22 17 24 7 5 19 0 12 86 1 8 0
2023/202480 3 18 4 3 5 16 1 2 4 7 6 11
2024/2025155 2 13 24 12 30 73 1 0 0 0 0 0
Totale 659